Tongying Shun
Papers
1
Total Citations
176
H-Index
1
About
Tongying Shun is a pioneering researcher in the field of microphysiological systems, with a primary focus on developing advanced organ-on-a-chip platforms for drug discovery and toxicity screening. Their most notable contribution is the creation of the OrganoPlate LiverTox™, a 3D microfluidic liver model that enables high-throughput compound toxicity testing using induced pluripotent stem cell (iPSC)-derived hepatocytes. This groundbreaking work, published in 2021 and cited over 176 times, represents a significant leap forward in replacing traditional animal models with more physiologically relevant human tissue constructs. Shun’s research integrates automation and microfluidics to achieve reproducible, scalable screening, addressing critical bottlenecks in preclinical drug development. Their achievements include demonstrating the model’s utility for detecting hepatotoxicity with high sensitivity, paving the way for safer pharmaceutical pipelines. By combining stem cell biology with cutting-edge engineering, Shun has established a new standard for liver-on-a-chip technology, earning recognition as a leader in the convergence of tissue engineering and toxicology. Their work continues to inspire innovations in personalized medicine and environmental risk assessment.
Research Focus
Key Achievements
Top Papers
- 1